Clinical trial registration: when to and why register by Peccin, Maria Stella
Editorial iSSN 1413-3555Rev. bras. fisioter., São Carlos, 
v. 11, n. 6, p. 419-507, nov./dec. 2007
CLINICAL TRIAL REGISTRATION
When to and why register
Clinical trials have been described lately as the gold standard in the evaluation of issues 
related to treatment and prevention in health1. The registration of clinical trials has been sug-
gested with the intention of respecting ethical reasons for those who participated in the study 
and were informed that they would be used to contribute to the advance of science, regardless 
of the results. It is also a way of guaranteeing that patients and professionals have access to in-
formation on studies which are recruiting volunteers for research, as well as trying to avoid the 
duplication of efforts of performing studies already conducted in the past, stimulating scientific 
knowledge and cooperation among research groups2.
The registration of clinical trials allows the identification of gaps in the existing knowledge 
in different areas, the observation of trends in the field of studies and the identification of spe-
cialists in the various areas3.
According to the World Health Organization (WHO), randomized control trials and clinical 
trials must be announced and registered before being commenced. This will allow the identifi-
cation of all clinical trials underway and their respective results, since not all of them are pub-
lished in scientific journals. The International Committee of Medical Journal Editors (ICMJE) 
suggests that scientific journal editors require from authors the registration number at the time 
of submission of papers4.
Recently the editors of peer-reviewed journals in the Lilacs and Scielo databases, such as the 
Brazilian Journal of Physical Therapy, received an official report stating that BIREME (Regional 
Library of Medicine) would begin requiring from journals that publish randomized control trials 
and clinical trials that they include, in the instruction to the authors, the recommendation for 
prior registration of clinical trials and that they request the identification number as condition 
of acceptance of the manuscript. This decision follows the instruction of WHO’s and ICMJE’s 
International Clinical Trials Registry Platform (ICTRP). ICMJE defines as a clinical trial every 
research project that is prospective and assigns patients to clinical or drug intervention, which may 
interfere in their health, with the purpose of comparing the cause/effect among studied groups.
ICMJE stated, in 2004, that its member journals would only accept for publication trials 
registered in freely accessible public registries, managed by non-profit organizations, having at 
their disposal mechanisms for validation of registered data and that allow electronic searches5.
WHO proposes a minimal set of information that must be registered on each trail, such as: 
unique identification number, trial registration date, secondary identities, sources of financing and 
support material, main sponsor, other sponsors, contact details for public queries, contact details for 
scientific queries, the study’s public title, the scientific title, recruitment countries, health problems 
studied, interventions, inclusion and exclusion criteria, type of study, date of recruitment of first vol-
unteer, intended sample size, recruitment status and primary and secondary result measurements.
With the purpose of providing greater visibility to validated Clinical Trial Registries, WHO 
launched its Clinical Trial Search Portal (http://www.who.int/ictrp/network/en/index.html), with 
an interface which allows simultaneous searches in various registries. In this portal, searches can 
be made by words, clinical trial title or identification number. The result shows all existing trials, 
in different phases of execution, with links to the full description in the corresponding Primary 
Clinical Trial Registry. WHO created its Network of Collaborating Clinical Trial Registers, which 
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will allow the exchange between Clinical Trial Registry producers in order to define good prac-
tices and quality control. The websites for primary clinical trial registration are: www.actr.org.
au (Australian Clinical Trials Registry) (Figures 1 and 2), www.clinicaltrials.gov (Figures 3 and 
4) and http://isrctn.org (International Standard Randomised Controlled Trial Number Register 
(ISRCTN)) (Figures 5 and 6). National registries are being created and, where possible, their 
registered clinical trials will be forwarded to those recommended by WHO.
The proposal by WHO, backed by PAHO (Pan-American Health Organization), has received 
support in the Americas. LATINREC – The Latin American Ongoing Clinical Trial Register – was 
created and developed by the Colombian branch of the Iberoamerican Cochrane Collaboration. 
This registry is about to start its operations, following ICTRP requirements. Canada has also 
adhered to the proposal, but is considering how to implement it6.                
In Brazil, discussions on the WHO proposal are being held not only by the authorities re-
sponsible for the Department of Sciences and Technology (DECIT), the Science, Technology and 
Strategic Input Bureau (CTIE), the Health Ministry, the National Health Surveillance Agency 
(ANVISA) and the National Council of Ethics in Research (CONEP), but also by editors, rep-
resentatives of the industry, of the patients, of foreign (Latinrec and SANCTR) and national 
(ICICT/FIOCRUZ) registries, and of researchers; in short, a significant number of interested 
parties, resulting in the decision to create a national registry. However, several measures need to 
be established for the implementation of a National Registry, including the Country’s registration 
policy6. Steps are being taken to bring this to fruition and to increase the visibility of the clinical 
trials undertaken within the national territory and by Brazilian researchers.
There are countless registered clinical trials already in existence, including those in the 
area of physical therapy and rehabilitation as a whole. There are few registrations by Brazilian 
physical therapists, but this outlook is certainly undergoing rapid changes especially given the 
fact that, at the last International Public Health Conference, the Latin American journals agreed 
to accept only registered clinical trials for publication within a year.
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